|
|
 |
 Mr. Engelson joined Cierra from Fluidigm Corporation where he was the Chief Financial Officer. Prior to joining Fluidigm, Mr. Engelson was a Venture Partner at Versant Ventures, and had previously been an Entrepreneur-in-Residence at Institutional Venture Partners. Previously, Mr. Engelson spent 13 years in various operating roles at Target Therapeutics where he led the early start-up into the field of Interventional Neuroradiology and eventually became its General Manager. He is the inventor of many medical device patents, and is the recipient of the 1998 Inventor of the Year Award from the Silicon Valley Intellectual Property Law Association. Mr. Engelson currently serves on the Board of Directors of Concentric Medical and Primaeva Medical, and is a co-founder of FlowCardia. Mr. Engelson holds B.S. and M.S. degrees in Microbiology and Bioengineering, respectively, from the University of California, San Diego, and has completed the Stanford Executive Program. Mr. Engelson is a Trustee of the U.C. San Diego Foundation.
|
